Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45.5M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
+2.73M
-
Total reported value, excl. options
-
$17.4M
-
Value change
-
+$4.64M
-
Put/Call ratio
-
0
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$1.70
Significant Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q1 2025
21 filings reported holding ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share as of Q1 2025.
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 45.5M outstanding shares and own 22.46% of the company stock.
Largest 10 shareholders include Knoll Capital Management, LLC (5.88M shares), Point72 Asset Management, L.P. (2.7M shares), Schonfeld Strategic Advisors LLC (599K shares), Parkman Healthcare Partners LLC (440K shares), NORTHERN TRUST CORP (199K shares), Perigon Wealth Management, LLC (146K shares), RENAISSANCE TECHNOLOGIES LLC (63.3K shares), SIGNATURE ESTATE & INVESTMENT ADVISORS LLC (47.3K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (34.8K shares), and BANK OF AMERICA CORP /DE/ (31K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.